Nopoulos noted that the survey would include administering psychedelics to a cohort of men with alcohol use disorder. Half of the participants will be administered psilocybin. In contrast, the other half will get ketamine, and neither the subjects nor the researchers will know which substance is being administered.
The researchers then analyzed the mood and emotional regulation capabilities of the participants during times…
The cannabis industry presents an array of high-paying job opportunities across various sectors—from finance and…
Recent studies have indicated a notable decrease in prescriptions for anti-anxiety medications, especially benzodiazepines, in…
We’ve assembled a list of fantastic brands and products from around the cannabis universe to…
If there's one thing I've learned from years of covering cannabis politics, it's that weed…
As we wrap up our deep dive into cannabis and exercise, I can't help but…